{"id":"https://openalex.org/W2588094065","doi":"https://doi.org/10.1089/jir.2016.0082","title":"Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients","display_name":"Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients","publication_year":2017,"publication_date":"2017-02-17","ids":{"openalex":"https://openalex.org/W2588094065","doi":"https://doi.org/10.1089/jir.2016.0082","mag":"2588094065","pmid":"https://pubmed.ncbi.nlm.nih.gov/28282271"},"language":"en","primary_location":{"id":"doi:10.1089/jir.2016.0082","doi":"https://doi.org/10.1089/jir.2016.0082","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jir.2016.0082","pdf_url":null,"source":{"id":"https://openalex.org/S109620152","display_name":"Journal of Interferon & Cytokine Research","issn_l":"1079-9907","issn":["1079-9907","1557-7465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Interferon & Cytokine Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103169075","display_name":"Mark Richard Nelson","orcid":"https://orcid.org/0000-0002-5944-6096","observed_orcids":["https://orcid.org/0000-0002-5944-6096"]},"institutions":[{"id":"https://openalex.org/I4210136304","display_name":"Chelsea and Westminster Hospital","ror":"https://ror.org/038zxea36","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799869770","https://openalex.org/I4210136304"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark Nelson","raw_affiliation_strings":["Chelsea and Westminster Hospital, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chelsea and Westminster Hospital, London, United Kingdom","institution_ids":["https://openalex.org/I4210136304"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015147550","display_name":"Rafael Rubio","orcid":"https://orcid.org/0000-0001-8132-4303","observed_orcids":["https://orcid.org/0000-0001-8132-4303"]},"institutions":[{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rafael Rubio","raw_affiliation_strings":["Hospital Universitario 12 Octubre, Centro de Actividades Ambulatorias, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario 12 Octubre, Centro de Actividades Ambulatorias, Madrid, Spain","institution_ids":["https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021984756","display_name":"Adriano Lazzarin","orcid":"https://orcid.org/0000-0003-2551-7754","observed_orcids":["https://orcid.org/0000-0003-2551-7754"]},"institutions":[{"id":"https://openalex.org/I4210133214","display_name":"IRCCS Ospedale San Raffaele","ror":"https://ror.org/039zxt351","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210133214","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Adriano Lazzarin","raw_affiliation_strings":["Scientific Institute Ospedale, San Raffaele, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scientific Institute Ospedale, San Raffaele, Milan, Italy","institution_ids":["https://openalex.org/I4210133214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034191125","display_name":"Svetlana Romanova","orcid":"https://orcid.org/0000-0002-7479-1023","observed_orcids":["https://orcid.org/0000-0002-7479-1023"]},"institutions":[{"id":"https://openalex.org/I4210117042","display_name":"Ministry of Health of the Russian Federation","ror":"https://ror.org/01p8ehb87","country_code":"RU","type":"government","lineage":["https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Svetlana Romanova","raw_affiliation_strings":["State Research Center-Institute of Biophysics, Russian Ministry of Health, Moscow, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"State Research Center-Institute of Biophysics, Russian Ministry of Health, Moscow, Russia","institution_ids":["https://openalex.org/I4210117042"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111592285","display_name":"Annie F. Luetkemeyer","orcid":"https://orcid.org/0000-0003-0911-1578","observed_orcids":["https://orcid.org/0000-0003-0911-1578"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Annie Luetkemeyer","raw_affiliation_strings":["Zuckerberg San Francisco General, University of California, San Francisco, San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zuckerberg San Francisco General, University of California, San Francisco, San Francisco, California","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109381574","display_name":"Brian Conway","orcid":"https://orcid.org/0000-0001-9930-7587","observed_orcids":["https://orcid.org/0000-0001-9930-7587"]},"institutions":[{"id":"https://openalex.org/I4210100817","display_name":"Vancouver Infectious Diseases Centre","ror":"https://ror.org/0159q3366","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210100817"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Brian Conway","raw_affiliation_strings":["Vancouver Infectious Diseases Centre, Vancouver, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vancouver Infectious Diseases Centre, Vancouver, Canada","institution_ids":["https://openalex.org/I4210100817"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046238828","display_name":"Jean\u2010Michel Molina","orcid":"https://orcid.org/0000-0001-8684-2214","observed_orcids":["https://orcid.org/0000-0001-8684-2214","https://orcid.org/0000-0002-6711-8754"]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"id":"https://openalex.org/I4387154366","display_name":"Universit\u00e9 Paris Diderot","ror":"https://ror.org/02n7qrg46","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I4387154366"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Michel Molina","raw_affiliation_strings":["Department of Infectious Diseases, H\u00f4pital Saint-Louis, Assistance Publique H\u00f4pitaux de Paris, University of Paris Diderot, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, H\u00f4pital Saint-Louis, Assistance Publique H\u00f4pitaux de Paris, University of Paris Diderot, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210144610","https://openalex.org/I4387154366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091701619","display_name":"Dong Zhu Xu","orcid":"https://orcid.org/0000-0003-2243-1883","observed_orcids":["https://orcid.org/0000-0003-2243-1883"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dong Xu","raw_affiliation_strings":["Bristol-Myers Squibb, Wallingford, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Wallingford, Connecticut","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Subasree Srinivasan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Subasree Srinivasan","raw_affiliation_strings":["Bristol-Myers Squibb, Wallingford, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Wallingford, Connecticut","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047147049","display_name":"Simon Portsmouth","orcid":"https://orcid.org/0000-0002-9853-4160","observed_orcids":["https://orcid.org/0000-0002-9853-4160"]},"institutions":[{"id":"https://openalex.org/I4210129916","display_name":"Shionogi (United States)","ror":"https://ror.org/02ww26h70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118477","https://openalex.org/I4210129916"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Simon Portsmouth","raw_affiliation_strings":["Shionogi Inc., Florham Park, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shionogi Inc., Florham Park, New Jersey","institution_ids":["https://openalex.org/I4210129916"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5047147049"],"corresponding_institution_ids":["https://openalex.org/I4210129916"],"apc_list":null,"apc_paid":null,"fwci":1.38,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.79656635,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"37","issue":"3","first_page":"103","last_page":"111"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10276","display_name":"Helicobacter pylori-related gastroenterology studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.9829999804496765},{"id":"https://openalex.org/keywords/daclatasvir","display_name":"daclatasvir","score":1.0},{"id":"https://openalex.org/keywords/hiv-hcv-coinfection","display_name":"HIV/HCV coinfection","score":0.8999999761581421},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.9649999737739563},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.8180000185966492},{"id":"https://openalex.org/keywords/hcv-genotypes","display_name":"HCV genotypes","score":0.8059999942779541},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.777999997138977},{"id":"https://openalex.org/keywords/response-guided-therapy","display_name":"response-guided therapy","score":0.8140000104904175},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7279999852180481},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.8119999766349792}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7663233280181885},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.7526158690452576},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6762021780014038},{"id":"https://openalex.org/C2776979040","wikidata":"https://www.wikidata.org/wiki/Q5207712","display_name":"Daclatasvir","level":5,"score":0.6698011159896851},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6533187627792358},{"id":"https://openalex.org/C2776461080","wikidata":"https://www.wikidata.org/wiki/Q7160835","display_name":"Pegylated interferon","level":5,"score":0.6160993576049805},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5986435413360596},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5369853973388672},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.503091037273407},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.47384244203567505},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.46997183561325073},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.45938804745674133},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.40127256512641907},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2875165343284607},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.16184616088867188}],"mesh":[{"descriptor_ui":"D000095022","descriptor_name":"Interferon Lambda","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007372","descriptor_name":"Interferons","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007372","descriptor_name":"Interferons","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007372","descriptor_name":"Interferons","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007378","descriptor_name":"Interleukins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060085","descriptor_name":"Coinfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1089/jir.2016.0082","doi":"https://doi.org/10.1089/jir.2016.0082","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jir.2016.0082","pdf_url":null,"source":{"id":"https://openalex.org/S109620152","display_name":"Journal of Interferon & Cytokine Research","issn_l":"1079-9907","issn":["1079-9907","1557-7465"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Interferon & Cytokine Research","raw_type":"journal-article"},{"id":"pmid:28282271","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28282271","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1109889602","https://openalex.org/W1966188054","https://openalex.org/W1970113462","https://openalex.org/W1980771473","https://openalex.org/W1987009823","https://openalex.org/W1987491896","https://openalex.org/W1993484328","https://openalex.org/W1996434966","https://openalex.org/W2003041902","https://openalex.org/W2049390811","https://openalex.org/W2063671198","https://openalex.org/W2068931925","https://openalex.org/W2078251659","https://openalex.org/W2082494671","https://openalex.org/W2088613968","https://openalex.org/W2097405564","https://openalex.org/W2100396313","https://openalex.org/W2104103604","https://openalex.org/W2120733999","https://openalex.org/W2121595515","https://openalex.org/W2122764811","https://openalex.org/W2124509162","https://openalex.org/W2126689013","https://openalex.org/W2127548135","https://openalex.org/W2150652264","https://openalex.org/W2157135427","https://openalex.org/W2394536734","https://openalex.org/W2460847961"],"related_works":["https://openalex.org/W1998737830","https://openalex.org/W2588103707","https://openalex.org/W2460847961","https://openalex.org/W96201458","https://openalex.org/W2122764811","https://openalex.org/W2101335057","https://openalex.org/W2410487329","https://openalex.org/W2514264306","https://openalex.org/W2121595515","https://openalex.org/W2094160256"],"abstract_inverted_index":{"To":[0],"evaluate":[1],"the":[2,54,83],"efficacy":[3],"and":[4,23,73,140,142,146,153],"safety":[5],"of":[6,14,71,85,132,189],"pegylated":[7],"interferon-lambda-1a":[8],"(Lambda)/ribavirin":[9],"(RBV)/daclatasvir":[10],"(DCV)":[11],"for":[12,53,62],"treatment":[13,158],"patients":[15,29,50,86,190],"coinfected":[16],"with":[17,159,169,185],"chronic":[18],"hepatitis":[19],"C":[20],"virus":[21,26],"(HCV)":[22],"human":[24],"immunodeficiency":[25],"(HIV).":[27],"Treatment-naive":[28],"were":[30,148],"assigned":[31],"to":[32,135,178,193],"cohort":[33,41,58,74,99,114],"A":[34,59,100,152],"[HCV":[35,43],"genotype":[36],"(GT)-2":[37],"or":[38,40,45,47],"-3]":[39],"B":[42,75,115],"GT-1(a":[44],"b)":[46],"-4].":[48],"All":[49],"received":[51,60,76],"Lambda/RBV/DCV":[52,160,170],"first":[55],"12":[56,65,96],"weeks;":[57],"Lambda/RBV":[61],"an":[63,172],"additional":[64],"weeks,":[66],"followed":[67],"by":[68],"24":[69],"weeks":[70],"follow-up,":[72],"response-guided":[77],"therapy.":[78],"The":[79],"primary":[80],"endpoint":[81],"was":[82,181],"proportion":[84,188],"who":[87],"achieved":[88,105,120],"a":[89,186],"sustained":[90],"virologic":[91],"response":[92],"at":[93],"post-treatment":[94],"week":[95],"(SVR12).":[97],"In":[98,113,156],"(n":[101,116],"=":[102,117],"104),":[103],"84.6%":[104],"SVR12":[106,121,167],"(95.0%":[107],"in":[108,111,123,126,129,150,171],"GT-2;":[109],"83.1%":[110],"GT-3).":[112],"196),":[118],"76.0%":[119],"(71.7%":[122],"GT-1a;":[124],"86.0%":[125],"GT-1b;":[127],"70.7%":[128],"GT-4).":[130],"Rates":[131],"discontinuation":[133],"due":[134,192],"adverse":[136],"events":[137],"(AEs)":[138],"(3.8%":[139],"6.1%)":[141,147],"serious":[143],"AEs":[144],"(5.8%":[145],"low":[149,187],"cohorts":[151],"B,":[154],"respectively.":[155],"addition,":[157],"had":[161],"little":[162],"impact":[163],"on":[164],"CD4":[165],"counts.":[166],"rates":[168],"HCV/HIV-coinfected":[173],"population":[174],"ranged":[175],"from":[176],"71.7%":[177],"95.0%.":[179],"Treatment":[180],"generally":[182],"well":[183],"tolerated,":[184],"discontinuing":[191],"AEs.":[194],"Clinical":[195],"trial":[196],"registration":[197],"NCT01866930.":[198]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-02-24T00:00:00"}